The Asia Pacific pharmaceutical drug delivery market is anticipated to reach US$ 473,700.1 Mn by 2027 from US$ 277,589.9 Mn in 2019. The market is projected to grow at a CAGR of 7.1% from 2020 to 2027.
The pharmaceutical drug delivery market in this region is growing primarily due to the increasing shortage of medicines. However, the low availability of R&D funding by government in developing economies limits the growth of the market in Asia Pacific. On the other hand, growing emerging markets is expected to have a positive impact on the growth of the Asia Pacific pharmaceutical drug delivery market in the coming years.Countries in Asia Pacific are emerging as attractive outsourcing locations for pharmaceutical industries. Low manufacturing and operating costs is the key factor that driving the growth of pharmaceutical industry in China and India, among others. Recent growth in the pharmaceuticals in both these countries indicate positive future outlook of the market players. Also, the growing domestic market and ongoing innovations in the drug delivery system are further opening new avenues for the pharmaceutical drug delivery players in APAC.
In 2019, China accounted for the largest share of the Asia Pacific pharmaceutical drug delivery market, and it is also expected to grow at a faster pace over the forecast period. The growing research activities in pharmaceutical drug delivery technologies and significant prevalence of disease are the key factors supporting the growth of the market in this country. Moreover, many markets players are focusing on geographic expansion in China.
China Pharmaceutical Drug Delivery Market, Revenue and Forecast to 2027 (US$ Mn)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET SEGMENTATION
By Route of Administration
- Oral Drug Delivery
- Injectable Drug Delivery
- Topical Drug Delivery
- Ocular Drug Delivery
- Pulmonary Drug Delivery
- Nasal Drug Delivery
- Transmucosal Drug Delivery
- Implantable Drug Delivery
By Application
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Other Applications
By End User
- Hospitals
- Home Care Settings
- ASC/Clinics
- Other End Users
By Country
Company Profiles
- 3M
- Antares Pharma
- Bayer AG
- BD
- GlaxoSmithKline plc
Asia Pacific Pharmaceutical Drug Delivery Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 277,589.9 Million |
| Market Size by 2027 | US$ 473,700.1 Million |
| Global CAGR (2020 - 2027) | 7.1% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Route of Administration
|
| Regions and Countries Covered | Asia-Pacific
|
| Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Asia Pacific Pharmaceutical Drug Delivery Market
- 3M
- Antares Pharma
- Bayer AG
- BD
- GlaxoSmithKline plc
Get Free Sample For